Autoimmunity

Benefits of exhaustion

Credit: Tristan Ben Mahjoub/Alamy

T cell exhaustion promotes viral persistence and is associated with a poor outcome in viral infections, but whether T cell exhaustion has a role in the clinical outcome of autoimmunity remains unknown. McKinney et al. now show that a transcriptional signature of CD8+ T cell exhaustion, which is inversely linked with a CD4+ T cell co-stimulation signature, predicts a low relapse rate in multiple autoimmune and inflammatory diseases.

“a signature of exhaustion in CD8+ T cells correlated with a low risk of relapse”

In order to investigate the mechanisms driving relapsing autoimmunity, the authors analysed the transcriptome of purified CD4+ and CD8+ T cells isolated from 44 patients with active, untreated anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) disease or from 23 patients with active, untreated systemic lupus erythematosus (SLE). Using several different analysis methods, they found that a gene expression signature in CD4+ T cells that is associated with co-stimulation correlated with disease relapse, whereas a signature of exhaustion in CD8+ T cells correlated with a low risk of relapse and thus, a better prognosis. This suggests that a transcriptional signature of CD8+ T cell exhaustion, in conjunction with a signature of low CD4+ T cell co-stimulation, may be associated with a favourable long-term outcome in autoimmune diseases. Indeed, CD8+ T cells from patients with a good disease prognosis were characterized by the expression of a distinct subset of exhaustion-associated co-inhibitory receptors. Furthermore, a subgroup of patients with both early and recurrent relapses could be identified from independent cohorts of patients with SLE, AAV or inflammatory bowel disease based on the absence of a CD8+ T cell exhaustion signature.

Persistent T cell receptor stimulation is known to promote T cell exhaustion, and the authors showed that co-stimulation via CD2 prevents the development of this phenotype in human CD8+ T cells in vitro. This inhibitory effect of CD2 signalling on exhaustion could be reversed by stimulation of the co-inhibitory receptor programmed cell death protein 1 (PD1). Therefore, the induction of exhaustion can be manipulated, at least in vitro, through PD1 and CD2.

Because most published datasets profile unseparated peripheral blood mononuclear cells, the authors identified a surrogate marker of the CD4+ T cell co-stimulation module that could be used in the datasets to independently validate these observations. They found that the presence of this surrogate marker correlated with a good response to combined interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and to vaccination for malaria, flu or yellow fever. By contrast, the presence of this surrogate marker of CD4+ T cell co-stimulation was associated with poor outcome in autoimmune and inflammatory diseases, such as idiopathic pulmonary fibrosis and type 1 diabetes.

Together, this study shows that, unlike in chronic viral infections, CD8+ T cell exhaustion is associated with a good outcome in autoimmune and inflammatory diseases. Therefore, manipulation of exhaustion may be a possible therapeutic mechanism to suppress autoreactivity.

References

  1. 1

    McKinney, E. F. et al. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature http://dx.doi.org/10.1038/nature14468 (2015)

Download references

Authors

Related links

Related links

Related links in Nature Research

Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. (in the press)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leavy, O. Benefits of exhaustion. Nat Rev Immunol 15, 468 (2015). https://doi.org/10.1038/nri3890

Download citation

Further reading